Carmen Suárez Fernández to Gene Expression Profiling
This is a "connection" page, showing publications Carmen Suárez Fernández has written about Gene Expression Profiling.
Connection Strength
0.038
-
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nat Med. 2018 06; 24(6):749-757.
Score: 0.020
-
Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma. Oncotarget. 2017 May 02; 8(18):30410-30421.
Score: 0.018